To the best of our knowledge, no study has investigated the circulating PD-1, PD-L1, (cPD-1, cPD-L1), and P53 expression levels in WT and hypernephroma pediatric patients or their correlation to relapse prediction. This evidence concerns the gene TP53 and renal cell carcinoma.